Intrapartum Maternal fever
Conditions
Interventions
Group 1:Spinal block using 5 mrg sufentanil and 3 mg ropivacaine in 3 ml saline
Epidural block using 0.8mg/ml ropivacaine and 0.4 mrg/ml sufentanil
Group 2:Epidural block using 0.8mg/ml ropivacaine and 0.4 mrg/ml sufentanil
Sponsors
Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. The pregnant women will plan to have a vaginal delivery in above four hospitals from March 25 in 2021 to May 15 in 2021; 2. The pregnant should be full-term, single fetus patients with cephalic presentation; 3. No fetus malformation; 4. Cervical dilatation 0-6 cm; 5. The patient agreed to participate and signed an informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant women have a fever before participation; 2. Pregnant women takes an antibiotics; 3. Pregnant women have any immediate caecarean section; 4. Pregnant woment have any condition below: placenta previa, placental abruption, severe preeclampsia/eclampsia, premature delivery, HIV-positive test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maternal temperature;visual analog scales (VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| whether was antibiotic used during the research;Duration of the first phase of labor;Duration of the second phase of labor;1 min and 5 min Apgar scores; | — |
Countries
China
Contacts
Public ContactXiaogao Jin
Department of Anesthesiology and Perioperative Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China
Outcome results
None listed